Splanchnic vein thrombosis: Clinical presentation, risk factors and treatment

Internal and Emergency Medicine

Volumn 5, Issue 6, 2010, Pages 487-494

  de Stefano, Valerio ^a   Martinelli, Ida ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Budd Chiari syndrome; Chronic myeloproliferative neoplasms; Extrahepatic portal vein obstruction; Inherited thrombophilia; Mesenteric vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT;

BUDD CHIARI SYNDROME; HUMAN; MESENTERIC VEIN; PORTAL VEIN; REVIEW; RISK FACTOR; SPLANCHNIC BLOOD FLOW; VEIN THROMBOSIS;

ANTICOAGULANTS; BUDD-CHIARI SYNDROME; HUMANS; MESENTERIC VEINS; PORTAL VEIN; RISK FACTORS; SPLANCHNIC CIRCULATION; VENOUS THROMBOSIS;

EID: 78649694757     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0413-6     Document Type: Review

References (50)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, European Group for the Study of Vascular Disorders of the Liver (2003) Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38: 364-371.
2. Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, Jafri W, Kumar A, Kudo M, Lesmana LA, Sharma BC, Shiha G, de Janaka Silva H, Members of the APASL Working Party on Portal Hypertension (2006) Consensus on extra-hepatic portal vein obstruction. Liver Int 26: 512-519.
3. Valla D (2004) Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 19: 204-211.
4. Almdal TP, Sorensen TI (1991) Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 13: 650-655.
5. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH (2009) Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival-an 18-year experience. Liver Int 29: 253-259.
6. Eapen CE, Mammen T, Moses V, Shyamkumar NK (2007) Changing profile of Budd-Chiari syndrome in India. Indian J Gastroenterol 26: 77-81.
7. Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23, 796 consecutive autopsies. World J Gastroenterol 12: 2115-2119.
8. Acosta S, Alhadad A, Svensson P, Ekberg O (2008) Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 95: 1245-1251.
9. Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M (2005) Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg 41: 59-63.
10. Dentali F, Ageno W, Witt D, Malato A, Clark N, Garcia D, McCool K, Siragusa S, Dyke S, Crowther M, WARPED consortium (2009) Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost 102: 501-504.
11. Darvish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL (2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39: 500-508.
12. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O'Grady J, Praseedom RK, Burroughs AK, Le Treut YP, Kirkegaard P, Rogiers X, Ericzon BG, Hockerstedt K, Adam R, Klempnauer J (2006) Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 44: 520-528.
13. Darvish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL, EN-Vie (European Network for Vascular Disorders of the Liver) (2009) Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 151: 167-175.
14. Senzolo M, Cholongitas EC, Patch D, Burroughs AK (2005) Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2: 182-190.
15. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106: 1042-1047.
16. Zeitoun G, Escolano S, Hadengue A, Azar N, Younsi ElM, Mallet A, Boudet MJ, Hay JM, Erlinger S, Benhamou JP, Belghiti J, Valla D (1999) Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30: 84-89.
17. Darvish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL (2006) Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 101: 83-90.
18. Kamath P (2006) Budd-Chiari syndrome: radiologic findings. Liver Transp 12: S21-S22.
19. Condat B, Valla D (2006) Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 3: 505-515.
20. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D (2000) Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32: 466-470.
21. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B (2001) Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49: 720-724.
22. Tessler FN, Gehring BJ, Gomes AS, Perrella RR, Ragavendra N, Busuttil RW, Grant EG (1991) Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol 157: 293-296.
23. Bradbury MS, Kavanagh PV, Chen MY, Weber TM, Bechtold RE (2002) Noninvasive assessment of portomesenteric venous thrombosis: current concepts and imaging strategies. J Comput Assist Tomogr 26: 392-404.
24. Kumar S, Sarr MG, Kamath PS (2001) Mesenteric vein thrombosis. N Engl J Med 345: 1683-1688.
25. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31: 587-591.
26. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR (2000) Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 96: 2364-2368.
27. Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell'Era A, Bucciarelli P, Mannucci PM (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44: 1528-1534.
28. Plessier A, Darwish Murad S, Hernandez Guerra M, European Network for Vascular Disorders of the Liver (EN-Vie) et al (2009) Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51: 210-218.
29. De Stefano V, Teofili L, Leone G, Michiels JJ (1997) Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 23: 411-418.
30. Dahabreh IJ, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M (2009) Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res 33: 67-73.
31. Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis DG, Ciminello A, Leone G, De Stefano V (2009) Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol 84: 126-127.
32. Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M, Grandi AM, Ageno W (2009) JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 113: 5617-5623.
33. Marchetti M, Castoldi E, Spronk HM, van Oerle R, Balducci D, Barbui T, Rosing J, Ten Cate H, Falanga A (2008) Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood 112: 4061-4068.
34. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A, Mannucci PM (2009) High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 50: 916-922.
35. Dentali F, Galli M, Gianni M, Ageno W (2008) Inherited thrombophilic abnormalities and risk of portal vein thrombosis. A meta-analysis. Thromb Haemost 99: 675-682.
36. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5: 642-645.
37. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol 92: 858-862.
38. Rautou PE, Plessier A, Bernuau J, Denninger MH, Moucari R, Valla D (2009) Pregnancy: a risk factor for Budd-Chiari syndrome? Gut 58: 606-608.
39. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP (1986) Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 90: 807-811.
40. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141: 663-669.
41. Fimognari FL, Violi F (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 3: 213-218.
42. Valla DC (2008) Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut 57: 1469-1478.
43. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44: 1308-1316.
44. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP (2004) Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre experience and review of the literature. J Hepatol 40: 172-180.
45. Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, Leebeek FW (2008) Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 100: 1084-1088.
46. Liu FY, Wang MQ, Fan QS, Duan F, Wang ZJ, Song P (2009) Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis. World J Gastroenterol 15: 5028-5034.
47. Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J, Group Budd-Chiari syndrome-transjugular intrahepatic portosystemic shunt (2008) TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135: 808-815.
48. Senzolo M, Patch D, Miotto D, Ferronato C, Cholongitas E, Burroughs AK (2008) Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis. Hepatology 48: 1352-1353.
49. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120: 490-497.
50. Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A (2007) Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 102: 2464-2470.